Skip to Content

Varicella virus vaccine Pregnancy and Breastfeeding Warnings

Varicella virus vaccine is also known as: Varivax

Varicella virus vaccine Pregnancy Warnings

Wild-type varicella can cause congenital varicella infection, but it is not known if vaccine strains may cause fetal harm. Fetal damage has not been documented with varicella vaccines. There are no controlled data in human pregnancy. All exposures to varicella containing vaccines during pregnancy or within three months prior to conception should be reported as suspected adverse reactions at AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.

Use is contraindicated. AU TGA pregnancy category: B2 US FDA pregnancy category: Contraindication Comments: -Pregnancy should be avoided for 1 to 3 months after vaccination.

See references

Varicella virus vaccine Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -Limited evidence from women vaccinated postpartum with the vaccine strain of varicella did not detect the virus, viral DNA, or viral antigen in breast milk. -The U.S. Centers for Disease Control and Prevention (CDC) consider the administration of live virus vaccines compatible with breast-feeding.

See references

References for pregnancy information

  1. "Product Information. Varivax (varicella virus vaccine live)." Merck & Co, Inc, West Point, PA.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. CDC. Centers for Disease Control and Prevention. "General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)and the American Academy of Family Physicians (AAFP)." MMWR Morb Mortal Wkly Rep 51(RR-2) (2002): 1-35
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. Cerner Multum, Inc. "Australian Product Information." O 0
  4. "Product Information. Varivax (varicella virus vaccine live)." Merck & Co, Inc, West Point, PA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.